240 related articles for article (PubMed ID: 24165446)
21. Changed women: the long-term impact of vaginal mesh complications.
Dunn GE; Hansen BL; Egger MJ; Nygaard I; Sanchez-Birkhead AC; Hsu Y; Clark L
Female Pelvic Med Reconstr Surg; 2014; 20(3):131-6. PubMed ID: 24763153
[TBL] [Abstract][Full Text] [Related]
22. Mesh Complication Rates Following Pelvic Radiation Therapy in Women With History of Synthetic Midurethral Sling Implantation.
Painter CE; Geynisman-Tan J; Samant N; Postlethwaite D; Ramm O
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e476-e480. PubMed ID: 33105345
[TBL] [Abstract][Full Text] [Related]
23. [Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].
Höfner K; Hampel C; Kirschner-Hermanns R; Alloussi SH; Bauer RM; Bross S; Bschleipfer T; Goepel M; Haferkamp A; Hüsch T; Kaufmann A; Kiss G; Kranz J; Oelke M; Pannek J; Reitz A; Rutkowski M; Schäfer W; Schulte-Baukloh H; Schumacher S; Seif C; Schultz-Lampel D
Urologe A; 2020 Jan; 59(1):65-71. PubMed ID: 31741004
[TBL] [Abstract][Full Text] [Related]
24. The impact of the 2011 US Food and Drug Administration transvaginal mesh communication on utilization of synthetic mid-urethral sling procedures.
Berger AA; Tan-Kim J; Menefee SA
Int Urogynecol J; 2021 Aug; 32(8):2227-2231. PubMed ID: 33206220
[TBL] [Abstract][Full Text] [Related]
25. Trends in internet search activity, media coverage, and patient-centered health information after the FDA safety communications on surgical mesh for pelvic organ prolapse.
Stone BV; Forde JC; Levit VB; Lee RK; Te AE; Chughtai B
Int Urogynecol J; 2016 Nov; 27(11):1761-1766. PubMed ID: 27209310
[TBL] [Abstract][Full Text] [Related]
26. Sacral colpopexy versus transvaginal mesh colpopexy in obese patients.
McDermott CD; Park J; Terry CL; Woodman PJ; Hale DS
J Obstet Gynaecol Can; 2013 May; 35(5):461-467. PubMed ID: 23756277
[TBL] [Abstract][Full Text] [Related]
27. Complications following the use of alloplastic materials in urogynecological surgery.
Renezeder K; Skala CE; Albrich S; Koelbl H; Naumann G
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):354-7. PubMed ID: 21764504
[TBL] [Abstract][Full Text] [Related]
28. One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series.
Lo TS
J Minim Invasive Gynecol; 2010; 17(4):473-9. PubMed ID: 20547113
[TBL] [Abstract][Full Text] [Related]
29. New considerations in the use of vaginal mesh for prolapse repair.
Rardin CR; Washington BB
J Minim Invasive Gynecol; 2009; 16(3):360-4. PubMed ID: 19423069
[TBL] [Abstract][Full Text] [Related]
30. Recurrence of prolapse after transvaginal mesh excision.
George A; Mattingly M; Woodman P; Hale D
Female Pelvic Med Reconstr Surg; 2013; 19(4):202-5. PubMed ID: 23797517
[TBL] [Abstract][Full Text] [Related]
31. Approval process for devices and mesh for surgical treatment of pelvic organ prolapse and urinary incontinence.
Nygaard I
Clin Obstet Gynecol; 2013 Jun; 56(2):229-31. PubMed ID: 23632639
[TBL] [Abstract][Full Text] [Related]
32. Female pelvic medicine and reconstructive surgery practice patterns: IUGA member survey.
Ghoniem G; Hammett J
Int Urogynecol J; 2015 Oct; 26(10):1489-94. PubMed ID: 26017893
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Placement and Removal or Revision of Transvaginal Mesh for Pelvic Organ Prolapse and Stress Urinary Incontinence in the Ambulatory Setting before and after the 2011 Food and Drug Administration Notification.
Polland A; Meckel K; Trop CS
Urol Pract; 2015 Jul; 2(4):160-164. PubMed ID: 37559260
[TBL] [Abstract][Full Text] [Related]
34. [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse].
Han JS; Zhang K; Zhu FL; Yao Y; Liang HM; Zhou LF; Guo HY
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):101-4. PubMed ID: 21426766
[TBL] [Abstract][Full Text] [Related]
35. Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries.
Reynolds WS; Gold KP; Ni S; Kaufman MR; Dmochowski RR; Penson DF
Neurourol Urodyn; 2013 Apr; 32(4):330-5. PubMed ID: 23001605
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Surgical Outcomes and Determinants of Litigation Among Women With Transvaginal Mesh Complications.
Zoorob D; Karram M; Stecher A; Maxwell R; Whiteside J
Female Pelvic Med Reconstr Surg; 2016; 22(6):404-409. PubMed ID: 27636217
[TBL] [Abstract][Full Text] [Related]
37. Medicolegal issues surrounding devices and mesh for surgical treatment of prolapse and incontinence.
Nosti PA; Iglesia CB
Clin Obstet Gynecol; 2013 Jun; 56(2):221-8. PubMed ID: 23563873
[TBL] [Abstract][Full Text] [Related]
38. Iatrogenic Pelvic Pain: Surgical and Mesh Complications.
Lee D; Chang J; Zimmern PE
Phys Med Rehabil Clin N Am; 2017 Aug; 28(3):603-619. PubMed ID: 28676367
[TBL] [Abstract][Full Text] [Related]
39. Estimating the early impact of the FDA safety communication on the use of surgical mesh.
Myers E; Geller E; Crane A; Robinson B; Matthews C
South Med J; 2013 Dec; 106(12):684-8. PubMed ID: 24305528
[TBL] [Abstract][Full Text] [Related]
40. [Questionnaire survey on the application of polypropylene mesh and sling in pelvic floor reconstruction surgery in Chinese IUGA members].
Chen J; Ren Y; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):608-614. PubMed ID: 31550777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
